A membrane-associated MHC-I inhibitory axis for cancer immune evasion
From the lab of Gabrielle’s Angels grantee Iannis Aifantis – their latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. Immune-checkpoint blockade has revolutionized cancer treatment, but some cancers, such as acute myeloid leukemia (AML), do not respond or […]
Read more